These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12438508

  • 1. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
    Perrien DS, Brown EC, Fletcher TW, Irby DJ, Aronson J, Gao GG, Skinner RA, Hogue WR, Feige U, Suva LJ, Ronis MJ, Badger TM, Lumpkin CK.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):904-8. PubMed ID: 12438508
    [Abstract] [Full Text] [Related]

  • 2. IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats.
    Perrien DS, Wahl EC, Hogue WR, Feige U, Aronson J, Ronis MJ, Badger TM, Lumpkin CK.
    Toxicol Sci; 2004 Dec; 82(2):656-60. PubMed ID: 15470231
    [Abstract] [Full Text] [Related]

  • 3. Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis.
    Wahl EC, Perrien DS, Aronson J, Liu Z, Fletcher TW, Skinner RA, Feige U, Suva LJ, Badger TM, Lumpkin CK.
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1466-72. PubMed ID: 16131855
    [Abstract] [Full Text] [Related]

  • 4. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 5. Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats.
    Shankar K, Hidestrand M, Liu X, Chen JR, Haley R, Perrien DS, Skinner RA, Lumpkin CK, Badger TM, Ronis MJ.
    J Bone Miner Res; 2008 Mar; 23(3):338-49. PubMed ID: 17967133
    [Abstract] [Full Text] [Related]

  • 6. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
    Schett G, Middleton S, Bolon B, Stolina M, Brown H, Zhu L, Pretorius J, Zack DJ, Kostenuik P, Feige U.
    Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
    [Abstract] [Full Text] [Related]

  • 7. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F.
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA.
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [Abstract] [Full Text] [Related]

  • 9. The impact of total enteral nutrition on distraction osteogenesis in a rat model.
    Lumpkin CK, Aronson J, Shen XC, Gao GG, Skinner RA, Badger TM.
    J Bone Miner Res; 1996 Jul; 11(7):962-9. PubMed ID: 8797117
    [Abstract] [Full Text] [Related]

  • 10. Skeletal toxicity associated with chronic ethanol exposure in a rat model using total enteral nutrition.
    Brown EC, Perrien DS, Fletcher TW, Irby DJ, Aronson J, Gao GG, Hogue WJ, Skinner RA, Suva LJ, Ronis MJ, Hakkak R, Badger TM, Lumpkin CK.
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1132-8. PubMed ID: 12023547
    [Abstract] [Full Text] [Related]

  • 11. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
    Sugano M, Tsuchida K, Makino N.
    Circulation; 2004 Feb 17; 109(6):797-802. PubMed ID: 14970118
    [Abstract] [Full Text] [Related]

  • 12. Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis.
    Wahl EC, Aronson J, Liu L, Liu Z, Perrien DS, Skinner RA, Badger TM, Ronis MJ, Lumpkin CK.
    Toxicol Appl Pharmacol; 2007 May 01; 220(3):302-10. PubMed ID: 17391719
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
    Yang SY, Wu B, Mayton L, Mukherjee P, Robbins PD, Evans CH, Wooley PH.
    Gene Ther; 2004 Mar 01; 11(5):483-91. PubMed ID: 14724688
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
    Bolon B, Campagnuolo G, Zhu L, Duryea D, Zack D, Feige U.
    Vet Pathol; 2004 May 01; 41(3):235-43. PubMed ID: 15133172
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R.
    Endocrinology; 1995 Jul 01; 136(7):3054-61. PubMed ID: 7789332
    [Abstract] [Full Text] [Related]

  • 16. The effect of transforming growth factor beta1 (TGF-beta1) on the regenerate bone in distraction osteogenesis.
    Ozkan K, Eralp L, Kocaoglu M, Ahishali B, Bilgic B, Mutlu Z, Turker M, Ozkan FU, Sahin K, Guven M.
    Growth Factors; 2007 Apr 01; 25(2):101-7. PubMed ID: 17891595
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1 receptor antagonist intervenes in signaling between different types of synoviocytes in rats with adjuvant arthritis.
    Zheng YQ, Wei W, Dai M, Zhu L, Jia XY, Wang Y.
    Acta Pharmacol Sin; 2006 Jan 01; 27(1):111-8. PubMed ID: 16364217
    [Abstract] [Full Text] [Related]

  • 18. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar 01; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 19. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors.
    Punzón C, Alcaide A, Fresno M.
    Int Immunopharmacol; 2003 Sep 01; 3(9):1293-9. PubMed ID: 12890427
    [Abstract] [Full Text] [Related]

  • 20. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.
    Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA.
    Hepatology; 1993 Nov 01; 18(5):1132-8. PubMed ID: 8225219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.